SAN DIEGO — Dapagliflozin provides significant benefits in the treatment of chronic kidney disease (CKD) even when initiated in patients with the most severe stages of the disease who are ...
The global population is progressively aging, to the extent that over 1.5 billion people worldwide will be aged 65 years or more by 2050, and the prevalence of end-stage renal disease in the ...
A government scheme in Coimbatore has successfully diagnosed early-stage chronic kidney disease in 941 individuals, emphasizing the importance of early detection and screening, particularly for ...
I think the biggest barrier in implementing a comprehensive population health strategy for CKD is too much of a focus on the later stages. A few years ago, we finally shifted our focus away from ...